Discover how next-generation functional assays, stability profiling and developability assessment are reshaping early biologics development.

From identifying the right therapeutic leads to building confidence in clinical candidates, effective characterisation needs to happen earlier and deliver increasingly relevant insights. This webinar will explore how biochemical and cellular functional assays can strengthen screening cascades, how developability can be integrated into early discovery, and how AI/ML can help translate these insights into better-designed biotherapeutics.

The discussion will bring together perspectives on functional characterisation, bioanalytical challenges, early stability and developability assessment, and scalable analytical approaches to explore how the industry can make faster, more informed development decisions.

• Enhance Candidate Selection – Use functional assays to identify, rank and characterise promising biotherapeutics.
• Integrate Developability Earlier – Bring stability and developability insights into discovery and candidate design.
• Improve Translation – Build greater confidence in the progression from preclinical characterisation to clinically relevant candidates.

This is your chance to see the latest tools in action, understand their real-world impact, and leave with practical takeaways to apply in your own research.